The U.S. Food and Drug Administration has recalled thousands of bottles of the antidepressant Duloxetine for potentially cancer-causing chemicals in the medication.

A market-ready ... according to new research findings. Experts at ETH Zurich, a leading Swiss public research university, ...

Thousands of bottles of a popular antidepressant have been pulled from the market after tests detected ... damage discovered in groundbreaking new study Duloxetine is a medication prescribed ...

The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...

The market for antidepressants is, however, getting more competitive after years of stagnation, with a string of new drugs on or approaching the market including AbbVie’s Vraylar (cariprazine ...

College students have opportunities to bend or break the rules after leaving home. It can be dangerous for those who take ...

Thousands of bottles of the antidepressant duloxetine, which is the generic version of Cymbalta, have been recalled due to the presence of a toxic chemical, according to a notice from the Food and ...

The U.S. Food and Drug Administration recalled thousands of bottles of antidepressants due to the medicines containing high levels of a cancer-causing chemical. Now, the FDA is assigning the ...

Recent studies on antidepressant-treatment response have focused on both aspects of pharmacogenetics research, identifying new candidate genes that may predict better treatment response for patients.

Sexual side effects have emerged as a major clinical concern with many of the newer antidepressants. Approximately 30% to 40% of patients on serotonergic antidepressants experience sexual dysfunction.

A large new study has found a link between taking antidepressants and a 5% increase in body weight. Some antidepressants were associated with a larger risk than others. Other factors like age and ...